Skip to main content

Table 2 Exposure history and clinical characteristics of healthcare workers by tobacco/nicotine use status (n = 4040)

From: SARS-Co-V2 infection in never, former, and current tobacco/nicotine users: a cohort study of 4040 Egyptian healthcare workers

  

Tobacco/nicotine use status

χ2

p-valuea

Total

Never

Former

Current

N = 4040

n = 3482

n = 79

n = 479

n (%)

n (%)

n (%)

n (%)

Pre-existing medical condition, yes

701 (17.4)

623 (17.9)

19 (24.1)

59 (12.3)

7.433

0.006

Contact with a confirmed case, yesb

1558 (38.6)

1361 (39.1)

31 (39.2)

166 (34.7)

3.505

0.173

Symptoms, yesb

1224 (30.3)

1088 (31.2)

27 (34.2)

109 (22.8)

14.949

0.001

Hospitalized, yesb

120 (3.0)

102 (2.9)

2 (2.5)

16 (3.3)

0.301

0.860

Symptoms severityb

n = 1224

n = 1088

n = 27

n = 109

  

 Mild

652 (53.3)

575 (52.8)

17 (63.0)

60 (55.0)

1.728

0.786

 Moderate

459 (37.5)

411 (37.8)

9 (33.3)

39 (35.8)

 Severe

113 (9.2)

102 (9.4)

1 (3.7)

10 (9.2)

SARS-Co-V2 test result

 Negative

3770 (93.3)

3239 (93.0)

75 (94.9)

456 (95.2)

3.410

0.065

 Positive at baseline

170 (4.2)

152 (4.4)

3 (3.8)

15 (3.1)

 Positive at follow-up

100 (2.5)

91 (2.6)

1 (1.3)

8 (1.7)

Among total SARS-CoV-2 positive

n = 270

n = 243

n = 4

n = 23

  

Symptoms, yesb

109 (40.4)

100 (41.2)

2 (50.0)

7 (30.4)

1.159

0.560

Symptoms severityb

n = 109

n = 100

n = 2

n = 7

  

 Mild

40 (36.7)

36 (36.0)

1 (50.0)

3 (42.9)

1.508

0.911

 Moderate

55 (50.5)

50 (50.0)

1 (50.0)

4 (57.1)

 Severe

14 (12.8)

14 (14.0)

0 (0.0)

0 (0.0)

  1. a Chi-squared test or Fisher’s Exact test
  2. b Numbers indicate any occurrence at either baseline or follow-up phases